Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

BUY
$412.59 - $563.26 $1.11 Million - $1.52 Million
2,693 Added 385.82%
3,391 $1.42 Million
Q2 2022

Aug 11, 2022

SELL
$463.67 - $597.16 $700,605 - $902,308
-1,511 Reduced 68.4%
698 $346,000
Q1 2022

May 12, 2022

SELL
$524.57 - $735.42 $255,465 - $358,149
-487 Reduced 18.06%
2,209 $1.24 Million
Q4 2021

Feb 09, 2022

BUY
$708.84 - $794.68 $1.71 Million - $1.91 Million
2,408 Added 836.11%
2,696 $2.04 Million
Q3 2021

Nov 10, 2021

SELL
$657.71 - $825.77 $351,217 - $440,961
-534 Reduced 64.96%
288 $215,000
Q2 2021

Aug 12, 2021

SELL
$576.64 - $649.04 $698,887 - $786,636
-1,212 Reduced 59.59%
822 $530,000
Q1 2021

May 13, 2021

BUY
$547.01 - $662.35 $105,572 - $127,833
193 Added 10.48%
2,034 $1.16 Million
Q4 2020

Feb 12, 2021

BUY
$510.68 - $643.45 $940,161 - $1.18 Million
1,841 New
1,841 $1.07 Million
Q3 2020

Nov 12, 2020

SELL
$454.43 - $535.6 $260,842 - $307,434
-574 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$334.87 - $493.06 $302,722 - $445,726
-904 Reduced 61.16%
574 $259,000
Q1 2020

May 13, 2020

SELL
$320.01 - $409.07 $131,204 - $167,718
-410 Reduced 21.72%
1,478 $518,000
Q4 2019

Feb 12, 2020

BUY
$319.73 - $374.2 $124,055 - $145,189
388 Added 25.87%
1,888 $699,000
Q3 2019

Nov 12, 2019

SELL
$304.55 - $345.24 $185,775 - $210,596
-610 Reduced 28.91%
1,500 $499,000
Q2 2019

Aug 12, 2019

BUY
$286.93 - $312.59 $605,422 - $659,564
2,110 New
2,110 $660,000
Q1 2019

May 10, 2019

SELL
$224.3 - $317.41 $358,880 - $507,856
-1,600 Closed
0 $0
Q4 2018

Feb 11, 2019

BUY
$220.1 - $309.0 $352,160 - $494,400
1,600 New
1,600 $372,000

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $8.89B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.